Leading Pharma, LLC

Ronald Gold began his generic pharmaceutical career in 1988 as a sales representative for quality companies such as Par Pharmaceuticals, Hi-Tech Pharmacal, Invamed Labs and others. In 1992, he founded Rising Pharmaceuticals as President/CEO, where he quarterbacked all aspects of the business, including sales and marketing, product development, accounting, budgets, government rebates, regulatory and other functions. In 2010, he oversaw the sale of Rising to Aceto Corporation (ACET), continuing as President/COO of Rising for two and a half years before exiting and starting Leading Pharma. A serial entrepreneur and industry leader, he also serves on the board of directors of several healthcare-focused entities.

Brian Shapiro is a senior pharmaceutical business development and sales executive with a 25-year accomplished tenure at Aceto Corporation (ACET), a global pharmaceutical distribution company, and its finished dosage form generic pharmaceuticals subsidiary, Rising Pharmaceuticals. At Aceto/Rising, Shapiro was responsible for the business development and sales activities for generic finished dosage form products, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). He has spearheaded Leading Pharma’s business development initiatives since 2014.

With more than 3 decades of experience working in the generic pharmaceutical industry, Elizabeth Guerrero has considerable expertise in contracting, negotiations, trade shows, new product distribution, and sales team management. Most recently, Guerrero was Director of Sales, National Accounts at Hikma. Prior to Hikma, she was Director, Corporate Accounts Managed Care at Taro. Her strengths in boosting sales figures, developing new marketing and promotional strategies, and all-around account management are evidenced by her many successes.